Cookie Consent
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Enzyme is pleased to announce that two of its flagship protocols — Enzyme Onyx and Enzyme Myso — will be ported to the Canton Network, making them natively available on both EVM-compatible chains and Canton. Expected to launch in early Q3, this marks a significant milestone in Enzyme's commitment to building financial infrastructure that is not only technically robust, but positioned at the forefront of the emerging institutional blockchain landscape.
Enzyme is pleased to announce that two of its flagship protocols — Enzyme Onyx and Enzyme Myso — will be ported to the Canton Network, making them natively available on both EVM-compatible chains and Canton. Expected to launch in early Q3, this marks a significant milestone in Enzyme's commitment to building financial infrastructure that is not only technically robust, but positioned at the forefront of the emerging institutional blockchain landscape.
Onyx users can now automate portfolio execution with 31Third
Improving transparency, NAV accuracy, and lifecycle reporting for on-chain vaults.
Reflecting on our 2025 achievements while laying the foundations for 2026
Enzyme, the global infrastructure for tokenized finance, and Particula, the prime rating provider for digital assets, today announced a strategic product partnership aimed at empowering asset managers and product issuers to streamline the launch of risk-rated tokenized investment products and facilitate institutional distribution across the onchain economy.
Enzyme is pleased to announce a strategic partnership with CV5 Capital, a leading regulated platform for launching institutional-grade hedge funds and digital asset funds in the Cayman Islands.
